As manager of the California HealthCare Foundation's (CHCF) Innovations for the Underserved plan, Margaret Laws' aim was "to reduce obstacles to efficient, affordable healthcare services for the underserved." The course to attaining this target took multiple types, including enhancing the availability of specialty care for low-income, uninsured, non-English speaking and rural Californians. Forte care was an incredibly constrained resource within the healthcare system, even for insured patients. In order to enhance accessibility, increasing specialist throughput became predominant; and this could frequently be attained through process improvements.
But in dialogues with faculty from Stanford University's Program in Biodesign (henceforth called Biodesign), Laws became intrigued by the possibility of new device technologies to enhance throughput and amplify capability. The question was whether the biodesign modernization progression educated at Stanford to develop apparatus for commercially attractive markets could be accommodated to focus on the needs of the underserved, and especially needs related to limited access to specialists. In order to answer that, the faculty from CHCF and the Biodesign program established a pilot program that would undertake a condensed version of the identification phase of the biodesign invention process, which comprised needs finding and needs filtering. This paper explores what was learned and that endeavor.
PUBLICATION DATE: September 15, 2009 PRODUCT #: OIT97-PDF-ENG
This is just an excerpt. This case is about STRATEGY & EXECUTION